Both in Pharmaceuticals
Genelux vs Polaryx Therapeutics
Over the past year GNLX returned −29.7% and PLYX returned −95.1%; their daily moves had a correlation of 0.01.
GNLX −29.7% PLYX −95.1%Growth of $1, one year, split-adjusted
| Metric | GNLX | PLYX |
|---|---|---|
| Price | $1.92 | $1.73 |
| Market cap | $86.9M | $86.2M |
| Today | −4.00% | −1.14% |
| 1 month | −26.2% | −16.4% |
| 6 months | −30.7% | −61.9% |
| Year to date | −56.0% | — |
| 1 year | −76.2% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 10,858.9× | — |
| Net cash | $18.7M | $11.5M |
| Dividend yield | — | — |
| Volatility (60d) | 65.8% | 68.0% |
| Short % of float | 12.9% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).